Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a ...

Bio-Techne rose 4% on a report that activist investor Ananym Capital Management has accumulated a stake in the maker of ...

Bio-Techne (TECH) has drawn fresh investor interest after teaming up with Refeyn on a four hour integrated workflow that links charge heterogeneity, molecular weight, and aggregation in bispecific ...

Is TECH a good stock to buy? We came across a bullish thesis on Bio-Techne Corporation on r/ValueInvesting by Dynaheir-be. In ...

The combined solutions support characterization capabilities for antibodies that cannot be achieved using standalone methods.

View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.

Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an ...

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...

MINNEAPOLIS, Sept. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media ...

Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, today announced a first‑of‑its‑kind integrated ...